Pharmacokinetics and Metabolism of Mitoxantrone

This publication has 74 references indexed in Scilit:

• Escalating dose regimen of intraperitoneal mitoxantrone: Phase I study—clinical and pharmacokinetic evaluation
  European Journal of Cancer and Clinical Oncology, 1988
• Arterielle regionale Chemotherapie fortgeschrittener Mammakarzinome
  Deutsche Medizinische Wochenschrift (1946), 1988
• Relationship of chemical structures of anthraquinones with their effects on the suppression of immune responses
  International Journal of Immunopharmacology, 1987
• DNA sequence preferences for the anti‐cancer drug mitoxanthrone and related anthraquinones revealed by DNase I footprinting
  FEBS Letters, 1986
• Mitoxantrone affects topoisomerase activities in human breast cancer cells
  Biochemical and Biophysical Research Communications, 1986
• Inhibition of the induction of alloreactivity with mitoxantrone
  International Journal of Immunopharmacology, 1986
• INTRATHECAL MITOZANTRONE FOR RESISTANT LEUKAEMIA
  The Lancet, 1985
• Inhibition of adriamycin-stimulated microsomal lipid peroxidation by mitoxantrone and ametantrone, two new anthracenedione antineoplastic agents
  Biochemical and Biophysical Research Communications, 1982
• Comparison of the interaction of antineoplastic aminoanthraquinone analogs with DNA using competitive fluorescence polarization
  Life Sciences, 1982
• Effect of 1,4-dihydroxy-5,8-bis (2-(2-hydroxyethylamino) ethyl amino)-9,10-anthracenedione(dihydroxyanthraquinone) on the replication of simian virus 40 chromosome
  Biochemical and Biophysical Research Communications, 1981